Review IDs Gut Microbiota Changes in Irritable Bowel

This article originally appeared here.
Share this content:
Review IDs Gut Microbiota Changes in Irritable Bowel
Review IDs Gut Microbiota Changes in Irritable Bowel

FRIDAY, June 17, 2016 (HealthDay News) -- Patients with irritable bowel syndrome (IBS) have alterations in their gut microbiota, with distinct alterations for Chinese patients, according to a review and meta-analysis published online June 14 in the Journal of Gastroenterology and Hepatology.

Xiaojun Zhuang, from the First Affiliated Hospital of Sun Yat-Sen University in Guangzhou, China, and colleagues conducted a meta-analysis to examine alterations of gut microbiota in IBS patients from China and other regions around the world. Data were included from 10 case-control studies detecting gut microbiota in IBS patients.

The researchers found that the standardized mean differences (SMDs) of Bifidobacteria, Lactobacillus, Escherichia coli, and Enterobacter were −1.42, −0.91, 0.83, and 0.57, respectively, in Chinese patients with IBS compared with healthy controls. No significant differences were seen in the SMDs of Bacteroides and Enterococcus in Chinese patients with IBS. In IBS patients from other regions, the SMDs of Bifidobacteria and Bacteroides were −0.76 and 1.17, respectively, while there were no significant differences in the SMDs of Lactobacillus, Escherichia coli, Enterobacter, and Enterococcus.

"There were alterations of gut microbiota in IBS patients and it implied that alterations of gut microbiota might be involved in the pathogenesis of IBS," the authors write. "However, the species-specific alterations of gut microbiota were different between IBS patients from China and other regions."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »